Medpage Today on MSN22h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Pharmabiz15h
Boehringer Ingelheim introduces Semintra 4 mg/ml oral solution in Europe to treat chronic kidney disease and hypertension in cats
Ingelheim, Germany Saturday, February 15, 2025, 12:00 Hrs [IST] ...
Managed Healthcare Executive8h
More Results for Nerandomilast Reported by BI, This Time for Progressive Pulmonary Fibrosis
Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...
TCTMD23h
More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin
Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
The Lancet21h
Sodium–glucose co-transporter inhibitors—who would have guessed?
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
BusinessMirror10h
region of oriental mindoro
Five new Asean Heritage Parks (AHPs) have been added to the network of top nature reserves and natural parks in the Southeast Asian region, the Asean Centre for Biodiversity (ACB) recently announced.